The numbers
The U.S. Environmental Protection Agency (EPA) has made a groundbreaking decision by placing microplastics and pharmaceuticals on a draft list of contaminants in drinking water for the first time. This move comes as part of the agency’s ongoing efforts to address growing public health concerns, with EPA Administrator Lee Zeldin stating, “This is a direct response to the concern of millions of Americans, who have long demanded answers about what they and their families are drinking every day.”
The draft Contaminant Candidate List will be open for public comment for 60 days, allowing citizens to voice their opinions on this critical issue. This is a significant step in the regulatory process, as the Safe Drinking Water Act mandates the EPA to publish an updated version of its Contaminant Candidate List every five years. The inclusion of microplastics and pharmaceuticals alongside other hazardous substances like PFAS highlights the urgency of the situation.
In a related initiative, the Department of Health and Human Services has announced a $144 million program called STOMP, aimed at measuring and monitoring microplastics in drinking water. Health Secretary Robert F. Kennedy Jr. remarked, “Today we mark a turning point — the EPA and HHS are acting together to confront microplastics as a human health threat.” This initiative will design experiments to better understand the effects of microplastics within the human body, addressing a growing concern about their impact on health.
Environmental groups have long advocated for the regulation of microplastics, petitioning the EPA to add them to the Unregulated Contaminant Monitoring Rule. Critics of the previous administration have pointed out that the Trump administration was criticized for rolling back regulations concerning toxic chemicals in the environment. This new draft list is seen as a necessary step towards rectifying that trend and ensuring safer drinking water for all Americans.
As the public comment period unfolds, experts and activists alike are closely watching the developments. Mary Grant, a representative from an environmental advocacy group, emphasized the importance of understanding the scope of the crisis in our drinking water, stating, “We need to understand the scope of the crisis in our drinking water.”
While the announcement marks a significant shift in policy, some observers remain skeptical. Katherine O’Brien, an environmental policy analyst, commented, “I think it’s fair to call this theater,” suggesting that more concrete actions may be necessary to truly address the problem of contaminants in drinking water.
Details remain unconfirmed regarding the specific timeline for implementing any new regulations based on the feedback received during the public comment period. However, the inclusion of microplastics and pharmaceuticals on the draft list is a clear indication that the EPA is taking steps to confront these pressing environmental and health issues.